Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02057731 · ClinicalTrials.gov registry record
Study of Glycogen Storage Disease Expression in Carriers
A clinical trial of Glycogen Storage Disease, sponsored by University of Florida.
- Completed
- Registry status
- 114
- Enrollment target
- 1
- Study location
NCT02057731: Completed study of Glycogen Storage Disease, sponsored by University of Florida.
NCT02057731 is a study of Glycogen Storage Disease that has completed, run by University of Florida. The registered enrollment target is 114 participants, above the 72-participant average among 3 other Glycogen Storage Disease trials with a reported enrollment target (58% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02057731, a study of Glycogen Storage Disease, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 114 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine whether carrier status for any type of glycogen storage disease (GSD) predisposes the carrier to GSD markers, like high cholesterol, by testing blood, urine, and saliva samples.
Primary Outcome
Blood test will be performed on all groups to measure markers of glycogen storage disease.
Conditions Studied
Interventions
- GENETIC Glycogen Storage Disease markers
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-07 |
What the finished NCT02057731 record still lists
NCT02057731 is an observational study that tracks outcomes without assigning an intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, above the 72-participant average among 3 other Glycogen Storage Disease trials with a reported enrollment target (58% higher).
The record links to 1 condition, with Glycogen Storage Disease appearing as the primary indexed condition, and to 1 intervention - of which Glycogen Storage Disease markers is the first listed.
NCT02057731 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02057731 about?
NCT02057731 is a clinical study titled "Study of Glycogen Storage Disease Expression in Carriers". The purpose of the study is to determine whether carrier status for any type of glycogen storage disease (GSD) predisposes the carrier to GSD markers, like high cholesterol, by testing blood, urine, and saliva samples.
What is the current status of trial NCT02057731?
This trial is currently completed. The enrollment target is 114 participants. The study started on 2014-02. Estimated completion is 2016-07.
What conditions does trial NCT02057731 study?
This clinical trial studies the following conditions: Glycogen Storage Disease.
What interventions are being tested in trial NCT02057731?
The interventions under investigation include: Glycogen Storage Disease markers (GENETIC).
Who is sponsoring clinical trial NCT02057731?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02057731 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glycogen Storage Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia